A Call for Physiopathological Ethics-Reference-Cited by-同舟云学术

A Call for Physiopathological Ethics

Published:2008-11 Issue:11 Volume:16 Page:1771-1772
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Lowenstein Pedro R

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference13 articles.

1. Progress reported in two studies of clinical gene transfer into the retina;Williams;Mol Ther,2008

2. Safety and efficacy of gene transfer for Leber's congenital amaurosis;Maguire;N Engl J Med,2008

3. Effect of gene therapy on visual function in Leber's congenital amaurosis;Bainbridge;N Engl J Med,2008

4. Phase I trial of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results;Hauswirth,2008

5. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial;Kaplitt;Lancet,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Translation in Central Nervous System Diseases: Ethical and Social Challenges;Handbook of Neuroethics;2014-09-29

2. Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor;Bioethics;2012-06-10

3. Predicting Harms and Benefits in Translational Trials: Ethics, Evidence, and Uncertainty;PLoS Medicine;2011-03-08

4. Accepting Risk in Clinical Research: Is the Gene Therapy Field Becoming Too Risk-averse?;Molecular Therapy;2009-11

5. Risk in Clinical Research: Size Matters!;Molecular Therapy;2009-11